CompletedNot applicableNCT05099107
Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment
Studying Centronuclear myopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vastra Gotaland Region
- Principal Investigator
- Niklas Darin, M.DVastra Gotaland Region
- Intervention
- Salbutamol (as Salbutamol Sulfate) 2 Mg Oral Tablet(drug)
- Enrollment
- 18 enrolled
- Eligibility
- 6-30 years · All sexes
- Timeline
- 2021 – 2025
Study locations (1)
- Sahlgrenska university hospital, Gothenburg, Västra Götaland County, Sweden
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05099107 on ClinicalTrials.govOther trials for Centronuclear myopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07021820Multispectral Optoacoustic Tomography for Advanced Imaging of Centronuclear MyopathyUniversity of Erlangen-Nürnberg Medical School
- RECRUITINGNCT06157268The Natural History and Muscle Fatigability of Patients With Congenital Myopathies.Radboud University Medical Center
- RECRUITINGNCT04064307Myotubular and Centronuclear Myopathy Patient RegistryNewcastle-upon-Tyne Hospitals NHS Trust
- RECRUITINGNCT00272883Molecular and Genetic Studies of Congenital MyopathiesBoston Children's Hospital